Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.

Hustig A, Bell C, Waddell R.

Int J STD AIDS. 2013 May;24(5):399-400. doi: 10.1177/0956462412472792. Epub 2013 Jun 14.

PMID:
23970709
2.
3.

Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.

Unemo M, Golparian D, Poto─Źnik M, Jeverica S.

Euro Surveill. 2012 Jun 21;17(25). pii: 20200.

4.

Challenges in implementing the new BASHH guidelines for the management of gonorrhoea.

Rodgers S, Murgatroyd M, Perez K, Kingston M, Lee V.

Int J STD AIDS. 2014 Feb;25(2):145-7. doi: 10.1177/0956462413495822. Epub 2013 Jul 19.

PMID:
23970641
5.

Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.

Golparian D, Ohlsson A, Janson H, Lidbrink P, Richtner T, Ekelund O, Fredlund H, Unemo M.

Euro Surveill. 2014 Jul 31;19(30). pii: 20862. Erratum in: Euro Surveill. 2014;19(32):pii/20874.

PMID:
25108533
6.

UK national guideline for the management of gonorrhoea in adults, 2011.

Bignell C, Fitzgerald M; Guideline Development Group; British Association for Sexual Health and HIV UK.

Int J STD AIDS. 2011 Oct;22(10):541-7. doi: 10.1258/ijsa.2011.011267.

PMID:
21998172
7.

Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.

Y Chen M, Stevens K, Tideman R, Zaia A, Tomita T, Fairley CK, Lahra M, Whiley D, Hogg G.

J Antimicrob Chemother. 2013 Jun;68(6):1445-7. doi: 10.1093/jac/dkt017. Epub 2013 Feb 6. No abstract available.

PMID:
23390207
8.

Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.

Gratrix J, Bergman J, Egan C, Drews SJ, Read R, Singh AE.

Sex Transm Dis. 2013 Nov;40(11):877-9. doi: 10.1097/OLQ.0000000000000033.

PMID:
24113412
9.

Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.

Wind CM, Schim van der Loeff MF, van Dam AP, de Vries HJ, van der Helm JJ.

Euro Surveill. 2017 Jan 5;22(1). pii: 30431. doi: 10.2807/1560-7917.ES.2017.22.1.30431.

10.

Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.

Khaki P, Bhalla P, Sharma A, Kumar V.

Indian J Med Microbiol. 2007 Oct;25(4):354-7.

11.

Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.

Bissessor M, Whiley DM, Fairley CK, Bradshaw CS, Lee DM, Snow AS, Lahra MM, Hocking JS, Chen MY.

Clin Infect Dis. 2015 Feb 15;60(4):557-63. doi: 10.1093/cid/ciu873. Epub 2014 Nov 3.

PMID:
25371490
12.

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.

Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, Sloots T, Whiley D.

J Med Microbiol. 2009 May;58(Pt 5):683-7. doi: 10.1099/jmm.0.007641-0.

PMID:
19369534
13.

Isolated pharyngeal Neisseria gonorrhoeae in heterosexual male contacts.

Thomson-Glover R, Brown R, Edirisinghe DN.

Int J STD AIDS. 2013 Dec;24(12):983-5. doi: 10.1177/0956462413491238. Epub 2013 Jul 22.

PMID:
23970625
14.

Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Ison CA, Hussey J, Sankar KN, Evans J, Alexander S.

Euro Surveill. 2011 Apr 7;16(14). pii: 19833.

15.

The outcome of oropharyngeal gonorrhoea treatment with different regimens.

Manavi K, Young H, McMillan A.

Int J STD AIDS. 2005 Jan;16(1):68-70.

PMID:
15705277
16.

Oropharyngeal gonorrhoea: rate of co-infection with sexually transmitted infection, antibiotic susceptibility and treatment outcome.

Manavi K, Zafar F, Shahid H.

Int J STD AIDS. 2010 Feb;21(2):138-40. doi: 10.1258/ijsa.2009.009167. Epub 2009 Nov 2.

PMID:
19884359
17.

Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.

Chan DJ, Tapsall J.

Int J STD AIDS. 2006 Jun;17(6):410-2.

PMID:
16734965
18.
19.

A retrospective comparative study of 2-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea.

Barbee LA, Kerani RP, Dombrowski JC, Soge OO, Golden MR.

Clin Infect Dis. 2013 Jun;56(11):1539-45. doi: 10.1093/cid/cit084. Epub 2013 Feb 13.

20.

One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia.

Read PJ, Limnios EA, McNulty A, Whiley D, Lahra MM.

Sex Health. 2013 Nov;10(5):460-2. doi: 10.1071/SH13077.

PMID:
24028864

Supplemental Content

Support Center